Currently out of the existing stock ratings of Matthew Phillips, 147 are a HOLD (74.62%), 36 are a BUY (18.27%), 14 are a SELL (7.11%).

Matthew Phillips

Work Performance Price Targets & Ratings Chart

Analyst Matthew Phillips, carries an average stock price target met ratio of 74.02% that have a potential upside of 20.67% achieved within 313 days. Previously, Matthew Phillips worked at MORGAN STANLEY, GUGGENHEIM.

Matthew Phillips’s has documented 410 price targets and ratings displayed on 28 stocks. The coverage was on Financial Services, Energy sectors.

Most recent stock forecast was given on TRV, The Travelers Companies at 06-Oct-2025.

Wall Street Analyst Matthew Phillips

Analyst best performing recommendations are on LMND (LEMONADE ).
The best stock recommendation documented was for LMND (LEMONADE ) at 3/4/2022. The price target of $28 was fulfilled within 25 days with a profit of $8.46 (43.3%) receiving and performance score of 17.32.

Average potential price target upside

AIZ Assurant AJG Arthur J Gallagher ALL The Allstate AON Aon PLC AXS AXIS Capital Holdings Ltd BRO Brown & Brown CB Chubb Ltd LMND Lemonade  PGR Progressive Corp RE Everest Re RNR Renaissancere Holdings Ltd TRV The Travelers Companies WLTW Willis Towers Watson Public Company WRB W. R. Berkley Corp ACGL Arch Capital Group Ltd HIG Hartford Financial Services Group ROOT Root MMC Marsh & McLennan Companies AIG American International Group BRP Brp Group AFG American Financial Group HIPO Hippo Holdings SIGI Selective Insurance Group THG The Hanover Insurance Group TRGP Targa Resources WTW Willis Towers Watson PLC EPD Enterprise Products Partners LP MPLX MPLX LP

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Aug-2025

$320

$37.54 (13.29%)

$246

20 days ago
(28-Aug-2026)

2/3 (66.67%)

$34.35 (12.03%)

110

Buy Since 06-Jul-2026

$320

$37.54 (13.29%)

$300

29 days ago
(19-Aug-2026)

11/12 (91.67%)

$41.69 (14.98%)

145

Buy Since 19-May-2025

$325

$42.54 (15.06%)

$310

1 months 10 days ago
(07-Aug-2026)

3/5 (60%)

$35.45 (12.24%)

161

Buy Since 03-Oct-2019

$355

$72.54 (25.68%)

$310

1 months 11 days ago
(06-Aug-2026)

12/14 (85.71%)

$58.6 (19.77%)

558

Buy Since 10-Oct-2025

$264

$-0.43 (-0.16%)

$248

8 months 29 days ago
(19-Dec-2025)

16/16 (100%)

$25.95 (10.90%)

191

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?